Weeden & Co Upgrades Baker Hughes (BHI) to Buy
Tweet Send to a FriendGet Alerts BHI Hot Sheet
Price: $47.53 +2.77%
Rating Summary:
9 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
9 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade BHI Now!
Weeden & Co upgraded Baker Hughes (NYSE: BHI) from Hold to Buy and raises their price target from $60-$62 to $70-$72.
The firm said, "Baker Hughes is beginning to deliver on its ambitious performance goals and appears well positioned to exploit the emerging multi year oil service cycle." The also said, "Robust margin expansion gives us renewed confidence the company is beginning to reap benefits from its multiple initiatives in organizational structure, technology enhancement, supply chain management and market penetration."
2011 EPS was raised from $3.40 to $3.95.
For more ratings news on Baker Hughes click here and for the rating history of Baker Hughes click here.
Shares of Baker Hughes closed at $62.32 yesterday, with a 52 week range of $35.62-$62.50.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm said, "Baker Hughes is beginning to deliver on its ambitious performance goals and appears well positioned to exploit the emerging multi year oil service cycle." The also said, "Robust margin expansion gives us renewed confidence the company is beginning to reap benefits from its multiple initiatives in organizational structure, technology enhancement, supply chain management and market penetration."
2011 EPS was raised from $3.40 to $3.95.
For more ratings news on Baker Hughes click here and for the rating history of Baker Hughes click here.
Shares of Baker Hughes closed at $62.32 yesterday, with a 52 week range of $35.62-$62.50.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
- UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
- CLSA Upgrades General Motors (GM) from Underperform to Buy
Create E-mail Alert Related Categories
Upgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
